Unlocking Ghana’s herbal goldmine

Ghana’s herbal medicine sector stands at a critical crossroads. The country possesses abundant medicinal plants, generations of traditional knowledge, capable scientists and a population that relies significantly on herbal remedies. Yet the value chain remains fragmented, largely informal and economically constrained.

Promising indigenous formulations often struggle to progress beyond local markets into hospitals, pharmacies and international markets. The problem is not necessarily a lack of therapeutic potential. Rather, it is the absence of an integrated system for scientific validation, product standardization, intellectual property protection, regulatory compliance, commercial manufacturing and market access.

Ghana must therefore establish a state-backed, public-private Herbal Product Starter Hub to transform promising traditional formulations into safe, standardized, certified and globally competitive products.

Bridging a fragmented system

Three major groups currently operate largely in isolation.

Traditional practitioners possess valuable, time-tested formulations but often lack the facilities and expertise required for toxicity testing, dosage standardization, stability studies, quality packaging and regulatory compliance. Many also fear that disclosing their knowledge could expose them to intellectual property theft or exploitation.

Universities and research institutions, including the Centre for Plant Medicine Research and the Kwame Nkrumah University of Science and Technology, possess considerable scientific expertise and laboratory capacity. However, researchers may remain disconnected from the practical knowledge, raw materials and community relationships of traditional practitioners.

Meanwhile, the Food and Drugs Authority and the Traditional Medicine Practice Council may be perceived by small producers primarily as enforcement bodies rather than accessible partners in product development. The cost and complexity of regulatory compliance can discourage small enterprises from entering the formal market.

This fragmentation costs Ghana valuable intellectual property, scientific discoveries, employment opportunities, export revenue and prospects for rural development.

What the Starter Hub should provide

The proposed hub would bring traditional practitioners, researchers, pharmacists, clinicians, regulators, lawyers, manufacturers, investors, marketers, farmers and other specialists into one coordinated innovation and commercialization system.

Its first responsibility should be to protect traditional knowledge. A confidential Intellectual Property Protection Vault could securely document formulations, ingredients, preparation methods, ownership arrangements and dates of disclosure before testing and development begin.

Protection must, however, extend beyond conventional patents. Some medicinal knowledge belongs collectively to families, lineages or communities. A Traditional Knowledge and Benefit-Sharing Charter should therefore guarantee prior informed consent, transparent contracts, fair compensation, community participation and accessible dispute-resolution procedures. Where knowledge is collectively owned, an agreed portion of the commercial proceeds should support community priorities through an independently managed trust.

The hub should also provide scientific services such as plant authentication, phytochemical screening, toxicological assessment, microbial analysis, dosage standardization, formulation development and stability testing. Where specific therapeutic claims are proposed, appropriately designed clinical studies should be undertaken.

Modern science should not displace traditional wisdom. Its role should be to verify, standardize, protect and elevate it.

A practical route to market

Not every herbal product requires the same level of evidence. The hub should establish a tiered pathway covering:

• general wellness and traditional-use products;
• standardized herbal medicines supported by quality and safety evidence; and
• clinically validated products making specific therapeutic claims.

Each category should have clearly defined requirements for evidence, manufacturing, labelling, registration, permissible claims and post-market monitoring.

The FDA and TMPC should maintain advisory desks within the hub to guide developers from the beginning of the development process rather than waiting to reject finished products. A single-window digital portal could allow applicants to submit documents, receive feedback and track registration milestones. Such support must not compromise the independence or statutory authority of the regulators.

The hub should also provide shared facilities that comply with Good Manufacturing Practice standards for extraction, drying, milling, blending, encapsulation, bottling, packaging, quality control and small-batch production. This would enable practitioners and small enterprises that cannot afford private factories to produce market-ready batches under controlled conditions.

Traditional preparations that are difficult to store, transport or dose could be responsibly developed into standardized teas, capsules, creams, tinctures or syrups without erasing their origins or severing their connection to the knowledge holders who developed them.

Protecting consumers and natural resources

Product oversight must continue after registration. Ghana needs a national herbal pharmacovigilance system through which healthcare professionals, traditional practitioners, consumers and manufacturers can report suspected adverse reactions, interactions, quality defects and misuse.

Approved products should carry secure digital identifiers or QR codes linked to information about their ingredients, manufacturing batches, laboratory results, registration status and expiry dates. This would help consumers identify certified products and enable defective or unsafe batches to be traced and recalled rapidly.

The hub must also protect the medicinal plants on which the industry depends. Commercial expansion based on uncontrolled harvesting would eventually destroy the sector’s natural foundation.

Certified out-grower networks should provide farmers with authenticated planting materials, technical assistance, fair purchasing arrangements and training in good agricultural and collection practices. Seed banks, nurseries, botanical gardens and conservation programmes should protect threatened species while supporting climate-resilient cultivation.

Traceability should begin at the farm, not at the factory.

Building a trusted Ghanaian brand

An Export Readiness Desk should help enterprises meet destination-market requirements relating to product classification, documentation, packaging, quality standards, trademarks, distribution and market entry.

A national “Validated in Ghana” quality mark could distinguish products that have completed approved processes for authentication, quality assessment, responsible sourcing, manufacturing and regulatory compliance.

The mark must not replace FDA registration or imply that every product has undergone the same level of clinical evaluation. It should clearly indicate the specific standards and level of evidence each product has met.

The hub should also function as a national training institution, offering fellowships, internships, apprenticeships and short courses. Practitioners could receive training in documentation, hygiene, dosage consistency, conservation, business management and regulatory compliance. Scientists and students could, in turn, learn to engage respectfully with traditional knowledge systems and the communities that sustain them.

Fair benefits and independent regulation

Commercialization must produce fair returns for the people and communities whose knowledge created the products. Benefit-sharing agreements should be concluded before development begins and should clearly define ownership, royalties, responsibilities, decision-making powers, risks and dispute-resolution procedures.

Traditional practitioners and knowledge-holding communities should retain a significant share of the commercial benefits. Universities, research institutions and the hub may also receive negotiated returns reflecting their contributions and risks. Every arrangement must be product-specific, transparently negotiated and structured so that all allocated benefits total 100 per cent.

The FDA and TMPC should not receive equity, royalties or percentages of product sales. Their services should be financed through transparent, fixed charges unrelated to approval outcomes or commercial performance.

Initial financing could combine government investment, private capital, development finance, university participation and support from philanthropic and international partners. A Herbal Innovation and Commercialisation Fund could provide grants, recoverable loans, matching funds and early-stage investment. Returns from successful products could replenish the fund and support future innovations.

Independent governance will be essential. The hub’s board should represent traditional practitioners, researchers, pharmacists, clinicians, legal and commercial experts, farming communities, consumers and civil society. Regulators should serve in advisory or observer roles without voting rights where such rights could create conflicts of interest.

Annual reports should disclose the hub’s finances, products under development, registration outcomes, community benefits, intellectual property arrangements, jobs created, export revenue, adverse-event investigations and conservation results.

Start with a pilot

Ghana should not attempt an immediate nationwide rollout. The first step should be a national feasibility study, stakeholder mapping, legal and regulatory review, community consultation and pilot-site selection.

The pilot should establish the intellectual property vault, laboratories, regulatory advisory desks, shared manufacturing facility, digital traceability system, commercialization office and training programmes.

A manageable number of promising products should then be taken through the entire development pathway. An independent evaluation should assess product quality, processing time, commercial performance, regulatory outcomes, practitioner satisfaction and community benefits. Successful components could subsequently be expanded through regional satellite hubs operating under uniform national standards.

Ghana’s botanical heritage is a public-health and economic resource hiding in plain sight. Unlocking it requires more than isolated laboratories, periodic enforcement exercises and scattered training programmes. It requires an integrated national system that connects traditional knowledge, science, regulation, manufacturing, conservation and markets.

The immediate priority should be to commission the feasibility study and stakeholder consultation required to produce a legal framework, governance model, financing plan, pilot-site recommendation, benefit-sharing charter and implementation timetable.

A well-designed Herbal Product Starter Hub could protect indigenous knowledge and biodiversity, improve consumer safety, create skilled employment, strengthen rural economies and build a resilient export industry based on products that are authentically Ghanaian and globally trusted.

Prof. Victor Wutor
Faculty of Public Health Pharmacy
Ghana College of Pharmacists

   Comments0